KTTA

Pasithea Therapeutics Corp.

$0.68-0.01 (-1.45%)
Price
MA20
Insider buy
Insider sell
Loading chart...
🤖 AI InsightHaiku 4.5

Pasithea Therapeutics Corp. (KTTA) is a publicly traded company with no SEC Form 4 insider transactions reported in the past 90 days. Form 4 filings disclose insider stock activity within two business days. The absence of recent filings can reflect either a stable insider holding pattern or simply no recent transactions to report. Historical filings, if any, remain searchable below.

Latest Insider Transactions

Showing 10 of 12 transactions (past 365 days)

KTTA
CFO
Award
$20K
Schneiderman Daniel H26,667 shares @ $0.75
Filed 2025-12-01Trade 2025-11-28
KTTA
Director
Award
$25K
Leahy Emer33,333 shares @ $0.75
Filed 2025-12-01Trade 2025-11-28
KTTA
CEO
Purchase
$25K
Marques Tiago33,333 shares @ $0.75
Filed 2025-12-01Trade 2025-11-28
KTTA
Director
Purchase
$25K
Dumesnil Simon33,333 shares @ $0.75
Filed 2025-12-01Trade 2025-11-28
KTTA
Director
Purchase
$100K
Steinman Lawrence133,333 shares @ $0.75
Filed 2025-12-01Trade 2025-11-28
KTTA
Director
Award
$0
Novak Alfred J42,913 shares @ $0.00
Filed 2025-10-27Trade 2025-10-24
KTTA
Director
Award
$0
Steinman Lawrence242,913 shares @ $0.00
Filed 2025-10-27Trade 2025-10-24
KTTA
CEO
Award
$0
Marques Tiago493,341 shares @ $0.00
Filed 2025-10-27Trade 2025-10-24
KTTA
Director
Award
$0
Dumesnil Simon42,913 shares @ $0.00
Filed 2025-10-27Trade 2025-10-24
KTTA
CFO
Award
$0
Schneiderman Daniel H317,266 shares @ $0.00
Filed 2025-10-27Trade 2025-10-24

Want to see more transactions?

Sign up for free to unlock more insider transactions and create watchlists.

Cluster Buy Signals →All Insider Signals →Top Insider Buying →